Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
News
markets
stocks
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Ltd (KILITCH) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,850
Aug 01, 2025 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹449.75
₹8.75 (1.98%)
449.75Low
Today’s Performance
449.75High
293.53Low
52 Week’s Performance
500.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day1.98%
  • 1 Week1.38%
  • 1 Month1.95%
  • 3 Months11.92%
  • 6 Months43.61%
  • 1 Year20.45%
  • 3 Years40.14%
  • 5 Years39.27%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.76
  • 52-Week Low (₹)293.53
  • 52-Week High (₹)500.00
  • Price-to-Book (X)*3.12
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*29.47
  • Earnings Per Share (₹)15.27
  • Market Cap (₹ Cr.)*770.90
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Chaos In Gaza: Starvation, Gunfire, And Desperate Crowds2:28Chaos In Gaza: Starvation, Gunfire, And Desperate Crowds
From Praise To Pressure: Trump’s Harsh Turn On Putin3:45From Praise To Pressure: Trump’s Harsh Turn On Putin
Trump’s Risky Oil Dream In Pakistan: Real Deal Or Mirage?2:04Trump’s Risky Oil Dream In Pakistan: Real Deal Or Mirage?
US President Donald Trump Taunts India, Backs Pakistan Pact Amid Tariff Row3:26US President Donald Trump Taunts India, Backs Pakistan Pact Amid Tariff Row
Hurun India Report Unveils Top 150 Real Estate Companies In India7:39Hurun India Report Unveils Top 150 Real Estate Companies In India
Dharmasthala Mass Burial Probe Deepens: 26 Days, 15 Sites & Still No Body Found3:30Dharmasthala Mass Burial Probe Deepens: 26 Days, 15 Sites & Still No Body Found
Goa’s Eco-Tourism Revolution 2025: Beyond Beaches To Forests And Waterfalls2:14Goa’s Eco-Tourism Revolution 2025: Beyond Beaches To Forests And Waterfalls
Adani Enterprises Q1FY26 Results | Group CFO Jugeshinder Singh Breaks Down Key Financials2:56Adani Enterprises Q1FY26 Results | Group CFO Jugeshinder Singh Breaks Down Key Financials
Rahul Gandhi, Tharoor & Shukla Split On India’s Economy, Us Trade Talks4:36Rahul Gandhi, Tharoor & Shukla Split On India’s Economy, Us Trade Talks
Malegaon Blast 2008: No Evidence Links Pragya Thakur Or Lt Col Purohit To Bomb Assembly Or RDX3:43Malegaon Blast 2008: No Evidence Links Pragya Thakur Or Lt Col Purohit To Bomb Assembly Or RDX
View more

bt_logoFAQ's

What was Kilitch Drugs (India) Ltd share price previously?
Kilitch Drugs (India) Ltd share price was up by 1.98% from the previous closing price of ₹441.00.
Who are peers of Kilitch Drugs (India) Ltd?
The peers of Kilitch Drugs (India) Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Glenmark Pharmaceuticals Ltd.
Who is/are the promoter/promoters of Kilitch Drugs (India) Ltd?
The promotor/promotors of Kilitch Drugs (India) Ltd are Mukund P Mehta, Bhavin M Mehta, Hemang Engineer, Mira Bhavin Mehta, Murti Vasudev Krishna, Venkita Subramanian Rajan, Pushpa Nyoupane, Dipen Jayantilal Jain.
What has been 52-week high of Kilitch Drugs (India) Ltd stocks?
The highest price of Kilitch Drugs (India) Ltd stock is ₹500.00 in the last 52-week.
What is the share price of Kilitch Drugs (India) Ltd (KILITCH) today on NSE?
As on Aug 01, 2025 Kilitch Drugs (India) Ltd (KILITCH)’s share price on NSE is Rs 449.75
What is the market cap of Kilitch Drugs (India) Ltd (KILITCH)?
The current market capitalisation of Kilitch Drugs (India) Ltd (KILITCH) is 770.90 crores
What is Kilitch Drugs (India) Ltd Share symbol?
The symbol of Kilitch Drugs (India) Ltd is KILITCH.
What is the PE ratio of Kilitch Drugs (India) Ltd (KILITCH)?
The current PE ratio of Kilitch Drugs (India) Ltd (KILITCH) is 29.47.
What is the PB ratio of Kilitch Drugs (India) Ltd (KILITCH)?
The current PB ratio of Kilitch Drugs (India) Ltd (KILITCH) is 3.12.
Today’s High & Low share prices of Kilitch Drugs (India) Ltd (KILITCH) on NSE?
Today, the share price of Kilitch Drugs (India) Ltd (KILITCH) on NSE touched a high of Rs 449.75 and a low of Rs 449.75
What price did Kilitch Drugs (India) Ltd (KILITCH) shares open on the NSE today?
On NSE, the share price of Kilitch Drugs (India) Ltd (KILITCH) opened at Rs 449
What is the 52-week high of Kilitch Drugs (India) Ltd (KILITCH)?
The 52-week high price of Kilitch Drugs (India) Ltd (KILITCH) is Rs 500.00
What is the 52-week low of Kilitch Drugs (India) Ltd (KILITCH)?
The 52-week low price of Kilitch Drugs (India) Ltd (KILITCH) is Rs 293.53

bt_logoAbout Kilitch Drugs

Kilitch Drugs (India) Ltd, incorporated in the year 1992, has its registered office in C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705, 91-022-27670322/27680913/65144185, 91-022-27680912. The main industry in which Kilitch Drugs (India) Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Kilitch Drugs (India) Ltd is/are Suryaprakash Maurya & Co. In the main management, Mukund P Mehta is chairman and Pushpa Nyoupane is the company secretary for Kilitch Drugs (India) Ltd.

  • MPM
    Mukund P MehtaChairman & Managing Director
  • BMM
    Bhavin M MehtaWhole-time Director
  • HE
    Hemang EngineerIndependent Director
  • MBM
    Mira Bhavin MehtaManaging Director
  • MVK
    Murti Vasudev KrishnaIndependent Director
  • VSR
    Venkita Subramanian RajanIndependent Director
  • PN
    Pushpa NyoupaneCompany Sec. & Compli. Officer
  • DJJ
    Dipen Jayantilal JainIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.